Abnormal fucosylation of cystic fibrosis mucin was previously shown using peroxidase conjugated lectins on ileal tissue sections. These abnormally fucosylated glycoproteins were investigated further using monoclonal antibodies to fucosyl oligosaccharides based on type 1 and type 2 blood group precursor chains. The results of this study, using monoclonal antibodies to blood group glycoproteins in cystic fibrosis, were negative, yet abnormal fucosylation had been found using lectin histochemistry.
The increased viscosity of the mucus in cystic fibrosis is still unexplained, despite much speculation.'`We have shown that there is a histochemical abnormality in the ileal mucus in cystic fibrosis, using peroxidase conjugated lectins. 6 zidine hydrochloride (DAB). The sections were counterstained with a weak haematoxylin, dehydrated, cleared and mounted in DPX.
Results
The sections were analysed for the intensity and distribution of staining as reported previously. 6 The intensity was graded as 1 + for minimal staining and 3 + for strong staining. Depending on the monoclonal antibody used, positive staining was present in goblet cell mucin, absorptive epithelial cells, basal cells in the crypts and the brush border. There was no difference in staining between mucins in cystic fibrosis and in controls with any of the antibodies used at any gestational age. With each monoclonal antibody, however, there was great variation in the pattern of staining between cases which was possibly due to differences in gestational age and secretor state, which was not known for any of the cases studied. Both Lewis a/b and Lewis x/y are changed in secretions under the influence ofthe (fig 3) . 
Fuc al Fuc al would be abnormally expressed in cystic fibrosis. This possibility was investigated using monoclonal antibody C14, which is directed against this epitope, but in fact no abnormal staining was demonstrable in cystic fibrosis. Expression of Ley is also controlled by secretor state, however, and as cystic fibrosis is not related to the latter such a result is perhaps not surprising." It has been suggested that blood group substances may be changed in cystic fibrosis," but this has yet to be proved. A prospective study using material fixed under controlled conditions with knowledge of the secretory state and blood group would be more informative.
LTG binds to other glycoproteins such as serum glycoproteins, and small amounts of these are present in mucus and are integrated into the cell membrane. Scanlin found increased fucosylation of membrane oligosaccharides in cystic fibrosis and has proposed a structure for the carbohydrate containing changed fucose.9 This is a biantennary N-linked glycopeptide in which the epitope recognised by C14 (Y hapten) is present. The Y hapten could be masked by sialic acid residues several of which were also present in this proposed structure.
Any abnormality in a carbohydrate chain which is secreted in mucus and is also carried on both glycoprotein and glycolipids of the cell membrane would explain several important facts about cystic fibrosis. 
